Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 09, 2026 22:28 ET | Source: MEDVI

MEDVi GLP-1 Investigation: What Consumer Data Shows About Compounded Telehealth Weight Loss Programs

Analysis examines MEDVi's compounded GLP-1 semaglutide telehealth model, FDA compounding framework, and prescription weight loss trends for 2026.
January 07, 2026 04:29 ET | Source: MEDVi

Is MEDVi a Trusted GLP-1 Supplier for 2026? What to Know Before Choosing a Telehealth Weight Loss Platform

New York City, NY, Jan. 07, 2026 (GLOBE NEWSWIRE) -- As demand for GLP-1 weight loss medications continues to rise in 2026, many consumers are actively searching for a reliable GLP-1 supplier...
December 27, 2025 13:40 ET | Source: MEDVi

Best Semaglutide For Weight Loss 2026: Is MEDVi the Best GLP-1 Supplier for a Sustainable Online Weight Loss Program?

New York City, NY, Dec. 27, 2025 (GLOBE NEWSWIRE) -- Intro As medical weight loss continues to evolve in 2026, the landscape of GLP-1 therapies has reached a pivotal moment with expanded...
October 15, 2025 15:57 ET | Source: MEDVi

MEDVi Unveiled: How the Doctor-Led MEDVi GLP-1 Program Is Democratizing Weight Loss with Compounded Semaglutide & Tirzepatide

New York City, NY, Oct. 15, 2025 (GLOBE NEWSWIRE) -- What Is MEDVi? – Inside the Doctor-Led GLP-1 Program Revolutionizing Modern Weight Management In an era where effective weight loss solutions...